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Abstract
Background:	Early	diagnosis	and	 therapy	 improves	outcomes	 in	heart	 failure	with	
severely	reduced	 left	ventricular	ejection	fraction	 (LVEF	≤35%),	but	some	patients	
may	remain	undiagnosed.	We	hypothesized	that	a	combination	of	electrocardiogram	
(ECG)	markers	may	identify	individuals	with	severely	reduced	LVEF.
Methods: From a community‐based study in the Northwest US (the Oregon Sudden 
Unexpected	Death	Study),	we	evaluated	the	prevalence	of	conventional	ECG	mark‐
ers	by	LVEF.	We	then	evaluated	the	association	of	nine	additional	ECG	markers	and	
LVEF.	We	validated	 the	correlation	of	 these	ECG	markers	and	LVEF	 in	a	 separate,	
large	health	system	in	Los	Angeles,	California.
Results: In the discovery population (n	=	1,047),	patients	with	LVEF	≤35%	were	twice	
as	likely	as	those	with	LVEF	>35%	to	have	≥1	conventional	ECG	abnormality.	In	the	
subset	without	conventional	ECG	abnormalities,	≥4	abnormal	ECG	markers	from	the	
expanded	panel	were	found	in	12%	vs.	1%	of	patients	with	LVEF	≤35%	and	>35%,	
respectively. In the validation population (n	=	9,742),	44%	with	LVEF	≤35%	and	17%	
with	LVEF	>35%	had	≥1	conventional	ECG	abnormality.	In	patients	without	conven‐
tional ECG abnormalities (n	=	7,601),	40%	with	LVEF	≤35%	and	5%	with	LVEF	>35%	
had	≥4	abnormal	ECG	markers	from	the	expanded	panel.	Each	additional	abnormal	
ECG	marker	from	the	expanded	panel	(range	0	to	≥4)	more	than	doubled	the	odds	of	
LVEF	≤35%.
Conclusions:	An	expanded	panel	of	easily	obtained	ECG	markers	correlated	strongly	
with severely reduced LVEF in two separate populations. This electrical surrogate 
score	could	facilitate	diagnosis	of	severely	reduced	LVEF,	and	warrants	prospective	
evaluation.
K E Y W O R D S
cardiomyopathy,	echocardiography,	electrocardiography,	heart	failure,	left	ventricular	
ejection	fraction,	left	ventricular	systolic	dysfunction
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1  | INTRODUC TION
Heart	failure	 (HF)	with	severely	reduced	left	ventricular	ejection	
fraction	 (LVEF	 ≤35%;	Owan	 et	al.,	 2006)	 remains	 a	major	 public	
health	 problem	 in	 the	USA,	with	 an	 average	5‐year	mortality	 of	
50%	 due	 to	 pump	 failure	 or	 sudden	 cardiac	 death	 (Roger	 et	al.,	
2004).
Early	 diagnosis	 and	 initiation	 of	 pharmacologic	 therapy	 for	
left	 ventricular	 systolic	 dysfunction	 (LVSD)	 reduces	morbidity	 and	
increases	 survival	 (Dargie,	 2001;	 Jong,	 Yusuf,	 Rousseau,	 Ahn,	 &	
Bangdiwala, 2003; SOLVD Investigators et al., 1992). Severely re‐
duced LVEF is detected by cardiac imaging, mostly echocardiography, 
but	 due	 to	 practical	 and	 cost‐effectiveness	 considerations,	 broad	
deployment	of	imaging	tools	for	screening	of	asymptomatic	patients	
in the community is not viable. Myocardial electrical remodeling is a 
consistent	feature	of	the	HF	syndrome	and	manifests	as	abnormali‐
ties	in	the	12‐lead	electrocardiogram	(ECG),	reported	in	a	variety	of	
patient	populations	(Aro	&	Chugh,	2016;	Davey,	2000;	Goldberger,	
1982;	 Ilkhanoff	 et	al.,	 2012;	 Lund	 et	al.,	 2013;	 Murkofsky	 et	al.,	
1998;	 O’Neal	 et	al.,	 2016;	 Opdahl	 et	al.,	 2014;	 Pavri	 et	al.,	 2008).	
However,	 published	 studies	 of	 the	 association	 between	 electrical	
remodeling	with	left	ventricular	(LV)	dysfunction	are	relatively	small	
and	have	focused	mainly	on	a	limited	number	of	individual	ECG	vari‐
ables,	largely	atrial	fibrillation,	left	bundle	branch	block	(LBBB),	and	
ventricular	 pacing	 (Aro	&	Chugh,	 2016;	Davey,	 2000;	Goldberger,	
1982;	 Ilkhanoff	 et	al.,	 2012;	 Lund	 et	al.,	 2013;	 Murkofsky	 et	al.,	
1998;	O’Neal	et	al.,	2016;	Opdahl	et	al.,	2014;	Pavri	et	al.,	2008).	We	
hypothesized	that	a	panel	of	additional	specific,	easily	obtained	ECG	
markers	could	identify	a	larger	proportion	of	patients	with	severely	
reduced	LVEF,	and	also	distinguish	these	patients	 from	those	with	
preserved LVEF.
We	 evaluated	 the	 correlation	 of	 nine	 expanded	 ECG	 mark‐
ers	with	LVEF	≤35%	from	the	ongoing	community‐based	Oregon	
Sudden Unexpected Death Study (Oregon SUDS) based in 
Portland, Oregon. Subsequently, we evaluated this association in 
a	separate	population	from	the	Cedars‐Sinai	Health	System	in	Los	
Angeles,	California.
2  | METHODS
2.1 | Discovery population
We	examined	the	association	of	ECG	risk	markers	with	echocardi‐
ographically	assessed	LV	function	among	participants	in	the	ongo‐
ing	Oregon	SUDS.	The	methods	and	rationale	of	the	Oregon	SUDS	
have	 been	 described	 previously	 (Chugh	 et	al.,	 2004;	 Narayanan	
et	al.,	2013)	Briefly,	the	study	prospectively	identifies	out‐of‐hos‐
pital	sudden	cardiac	arrest	(SCA)	cases	occurring	in	the	Portland,	
OR metro area, and conducts comparisons with control subjects 
from	the	same	geographic	area.	Clinical	history	for	study	partici‐
pants,	including	cardiac	tests	and	imaging,	is	obtained	from	avail‐
able medical records. For this analysis, cardiac arrest cases and 
control	 subjects	 enrolled	 from	 2002	 to	 2015	 were	 pooled	 and	
included	 if	 they	had	LVEF	assessed	by	echocardiography	and	an	
ECG	available	in	existing	medical	records;	if	>1	echocardiogram	or	
ECG was available, the one closest to arrest/ascertainment was 
obtained.	For	SCA	cases,	 the	ECG	and	echocardiogram	were	 re‐
quired	to	have	been	performed	prior,	and	unrelated	to	the	cardiac	
arrest event.
2.2 | Validation population
The	association	of	LVEF	≤35%	with	myocardial	electrical	remodeling	
as measured by the expanded ECG panel was validated in a large, 
separate	 patient	 population	 from	 the	 Cedars‐Sinai	 Health	 System	
(Los	 Angeles,	 CA).	 Patients	 with	 a	 transthoracic	 echocardiogram	
performed	from	January	1	to	December	31,	2015	were	retrospec‐
tively	identified	from	the	hospital’s	echocardiography	laboratory	da‐
tabase, and the most recent test was analyzed. LVEF was calculated 
using	 the	 biplane	method	 of	 disk	 summation	 (modified	 Simpson’s	
rule)	based	on	left	ventricular	end‐diastolic	and	end‐systolic	volumes	
measured	 in	 the	 apical	 two‐	 and	 four‐chamber	 views	 (Lang	 et	al.,	
2015).	Patients	with	LVEF	≤35%	were	considered	to	have	severely	
reduced	LV	systolic	function.
Subsequently, the MUSE (GE Healthcare, Milwaukee, WI) elec‐
trocardiographic	database	management	system	and	archive	of	all	
the ECGs recorded at the medical center was queried to obtain the 
digital	ECG	closest	to	the	echocardiogram	of	each	patient.	Patients	
were	 included	 in	 this	analysis	 if	 they	were	over	16	years	old	and	
had	a	resting	12‐lead	ECG	performed	within	14	days	of	the	echo‐
cardiogram	 (67%	of	 all	 patients	with	 an	echo	had	an	ECG	within	
14	days).
The	study	was	approved	by	the	 Institutional	Review	Boards	of	
Cedars‐Sinai Medical Center, Oregon Health and Science University, 
and all participating hospitals and health systems, and subjects pro‐
vided	informed	consent	as	directed	by	these	boards.
2.3 | ECG markers
The	nine	parameters	of	the	expanded	ECG	panel	were	the	following:	
heart rate, P‐wave duration, PR interval, QRS duration, QTc interval 
(Bazett’s	correction),	frontal	QRS‐T	angle	(calculated	as	the	absolute	
difference	between	the	frontal	QRS	axis	and	T‐wave	axis	with	val‐
ues	0°	 ̶	180°),	delayed	QRS	transition	zone	(R‐wave	amplitude	less	
than S‐wave amplitude in lead V4),	 delayed	 intrinsicoid	 deflection	
(defined	as	R‐peak	time	≥50	ms	in	lead	V5 or V6),	and	left	ventricu‐
lar hypertrophy (LVH; by Cornell voltage or Sokolow‐Lyon criteria). 
In	addition,	the	ECG	was	evaluated	for	rhythm,	presence	of	LBBB,	
and	 acute	 ST‐elevation	 myocardial	 infarction	 (MI).	 In	 the	 Oregon	
SUDS, we analyzed archived resting 12‐lead ECGs with paper speed 
of	25	mm/s	 and	 calibration	of	10	mm/mV,	 as	previously	described	
(Panikkath et al., 2011; Teodorescu et al., 2011). QRS transition 
zone,	intrinsicoid	deflection,	LVH,	LBBB,	and	acute	ST	elevation	MI	
were	determined	by	manual	review.	At	Cedars‐Sinai,	computerized	
measurements	of	all	parameters	were	available	from	the	digital	ECG	
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reports.	Clinically	over‐read	diagnoses	were	used	to	identify	paced	
ECG	 rhythm,	 atrial	 fibrillation/flutter	 (AF),	 LVH,	 LBBB,	 and	 acute	
ST‐elevation	MI.	The	reliability,	sensitivity,	and	specificity	of	these	
diagnostic	algorithms	have	been	previously	demonstrated	(Guglin	&	
Thatai, 2006). From the total ECGs available, we excluded ECGs with 
evidence	of	acute	ST‐elevation	MI.
2.4 | Statistical methods
As	a	first	step,	we	evaluated	the	association	of	ECG	findings	con‐
ventionally associated with LVEF that included ventricular pacing, 
AF,	or	presence	of	LBBB.	In	Oregon	SUDS,	we	excluded	ventricu‐
lar	paced	ECGs	a	priori,	and	therefore,	ventricular	paced	rhythms	
were	not	included	in	analyses	of	conventional	ECG	abnormalities.	
Subsequently,	we	analyzed	the	remaining	larger	subset	of	patients	
without conventional ECG abnormalities, to examine associations 
between	the	expanded	panel	of	9	ECG	markers	and	LVEF.	We	used	
chi‐square	 tests	 for	 univariate	 associations,	 and	 automated	 step‐
wise logistic regression to test the multivariable‐adjusted associa‐
tion	of	each	ECG	marker,	with	LVEF	≤35%	as	the	outcome	and	the	
nine individual ECG markers as predictors. Potential collinearity 
was evaluated in both populations by calculating the variance in‐
flation	 factor	 (1/[1	−	R2])	 for	 each	of	 the	nine	ECG	markers	using	
SAS	PROC	REG,	where	R2 was the R‐squared	 for	 the	model	with	
variable Xj as the dependent variable, and all other ECG markers 
as	the	independent	variables.	Variance	inflation	factors	were	<1.3	
for	 all	 ECG	 variables,	 indicating	 no	multicollinearity.	We	 ran	 two	
logistic regression models, one with ECG variables as continu‐
ous	predictors	 if	appropriate,	and	the	second	model	with	all	ECG	
variables dichotomized. Variables meeting model entry criteria 
(p	<	0.30)	were	retained	if	p	<	0.10	in	the	final	model.	Continuous	
ECG variables were dichotomized at clinically accepted cut‐points: 
heart	rate	>85	bpm;	QRS	duration	>110	ms;	QTc	interval	≥460	ms	
for	men	 and	≥470	ms	 for	women;	QRS‐T	 angle	 >90°;	 PR	 interval	
>200 ms; and P‐wave duration >110 ms. The remaining variables 
were dichotomous only: delayed QRS transition zone, delayed in‐
trinsicoid	deflection,	and	LVH.
2.4.1 | Summed expanded panel of abnormal 
ECG markers
Finally,	in	both	populations	we	calculated	a	sum	for	the	expanded	
abnormal	ECG	marker	panel,	 in	which	each	variable	significant	at	
p	<	0.10	 in	 either	 the	 continuous	 or	 categorical	 models	 was	 as‐
signed	one	point	(the	unweighted	panel).	As	a	sensitivity	analysis,	
a weighted panel was also constructed, with each ECG parameter 
weighted by its odds ratio (OR) in the categorical model rounded 
to	 the	nearest	 integer.	 The	 sum	of	 the	number	of	 abnormal	ECG	
markers	was	modeled	as	 a	predictor	of	 LVEF	≤35%	using	 logistic	
regression.	Model	 fit	was	 evaluated	with	 the	Hosmer‐Lemeshow	
goodness	 of	 fit	 test,	 and	 model	 calibration	 with	 the	 C‐statistic. 
Sensitivity,	 specificity,	 positive	 predictive	 value	 (PPV),	 and	 nega‐
tive	predictive	value	(NPV)	were	calculated	for	the	expanded	ECG	
panel.
3  | RESULTS
3.1 | Oregon SUDS discovery population
Between	February	1,	2002	and	January	31,	2015,	1,047	subjects	
(560	cardiac	arrest	cases,	487	controls)	with	both	ECG	and	LVEF	as‐
sessed	by	echocardiogram	were	identified	from	the	Oregon	SUDS.	
Echocardiograms	 were	 performed	 a	 median	 of	 192	days	 prior	 to	
arrest/ascertainment	 (interquartile	 range	 21–702	days),	 and	 ECGs	
were	 performed	 a	median	 of	 163	days	 from	 the	 echocardiogram	
(IQR 6–565 days). In Oregon SUDS, ECGs with paced ventricu‐
lar	 rhythms	were	 excluded	 a	 priori.	After	 further	 excluding	ECGs	
with acute ST elevation MI (n	=	33),	 195	 of	 1,014	 subjects	 (19%)	
had	 LVEF	 ≤35%.	 Conventional	 ECG	 abnormalities	 (LBBB	 or	 AF)	
were	 observed	 in	 62	 (32%)	 of	 195	 subjects	with	 LVEF	≤35%	 and	
122	 (15%)	of	819	subjects	with	LVEF	>35%	 (p	<	0.001).	The	pres‐
ence	of	LBBB	was	significantly	associated	with	LVEF	≤35%	(OR	4.4,	
95%	 confidence	 interval	 [CI]	 2.7–7.0),	 while	 AF	was	 not	 (OR	 1.4,	
F I G U R E  1  Association	of	abnormal	electrocardiogram	(ECG)	
markers	with	left	ventricular	ejection	fraction	(LVEF).	Among	all	
patients (n	=	9,742),	≥1	conventional	abnormal	ECG	marker	was	
present	in	44%	of	patients	with	LVEF	≤35%	(in	dark	blue).	Among	
patients without conventional ECG abnormalities, an additional 
21%	of	patients	with	LVEF	≤35%	had	≥4	abnormal	markers	on	the	
expanded	ECG	panel	(in	cross‐hatch).	Use	of	the	expanded	panel	
plus	conventional	markers	increased	identification	of	abnormal	
ECG	findings	from	44%	to	65%	among	patients	with	LVEF	≤35%.	
Conventional	ECG	abnormalities	were	left	bundle	branch,	atrial	
fibrillation/flutter,	or	paced	rhythms.	The	expanded	abnormal	ECG	
panel included resting heart rate >85 bpm, QRS duration >110 ms, 
QTc	interval	≥460	ms	for	men	and	≥470	ms	for	women,	delayed	
QRS	transition	zone,	delayed	intrinsicoid	deflection,	and	QRS‐T	
angle >90°
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95%	CI	0.9–2.2).	Among	the	remaining	830	subjects	(423	cases,	407	
controls) in sinus rhythm without conventional ECG abnormalities 
(16%	with	 LVEF	≤35%),	 all	 ECG	parameters	were	 significantly	 as‐
sociated	with	 LVEF	 ≤35%	 in	 univariate	 comparisons	 (p	≤	0.01).	 In	
multivariable models, heart rate, QRS duration, QRS‐T angle, QRS 
transition zone, and PR‐interval remained independently associated 
with	LVEF	≤35%.	 In	 this	subset,	12%	of	patients	with	LVEF	≤35%	
and	1%	of	patients	with	LVEF	>35%	had	≥4	of	 the	abnormal	ECG	
markers	 from	 the	 expanded	 panel	 (p	<	0.001).	 When	 these	 ECG	
parameters were combined to construct the unweighted summed 
expanded ECG panel, a 1‐unit increase in the panel sum was as‐
sociated	with	2.5‐fold	higher	odds	of	LVEF	≤35%	(OR	2.5;	95%	CI	
2.0–3.1; C‐statistic	0.763).	The	weighted	panel	performed	similarly	
(C‐statistic	0.747).
3.2 | Cedars‐Sinai validation population
A	total	of	9,742	consecutive	patients	(9.1%	with	LVEF	≤35%)	had	
a	 transthoracic	 echocardiographic	 study	 performed	 between	
January 1 and December 31, 2015 at the Cedars‐Sinai Medical 
Center,	 with	 a	 12‐lead	 ECG	 available	 within	 14	days	 of	 the	
echocardiogram	(same	day	in	62%,	within	3	days	in	93%).	After	ex‐
cluding	68	patients	with	acute	ST‐elevation	MI,	1,896	(20%)	of	the	
remaining	9,674	patients	had	at	least	one	major	ECG	abnormality	
clinically	accepted	to	be	associated	with	HF:	LBBB,	AF,	or	paced	
rhythm.	After	further	excluding	177	subjects	with	other	arrhyth‐
mias	or	missing	data,	7,601	subjects	remained	in	the	final	analysis.	
Among	these	patients,	severely	reduced	LVEF	≤35%	was	present	
in	6.1%.
TA B L E  1  Patient	demographics	and	electrocardiogram	(ECG)	parameters	based	on	category	of	left	ventricular	ejection	fraction	(LVEF)	in	
the Cedars‐Sinai Health System validation population
Cedars‐Sinai validation populationa (n = 9,742)
LVEF ≤35% (n = 875) LVEF >35% (n = 8,799) p‐Value
Demographics
Male 648	(74%) 4,554	(52%) <0.001
Age 68.0 ± 16.1 68.7	±	17.3 0.23
Conventional	abnormal	electrocardiographic	findings
Left	bundle	branch	block	(LBBB) 101	(12%) 266	(3%) <0.001
Atrial	fibrillation/flutter 128	(15%) 864	(9%) <0.001
Ventricular paced rhythm 186	(21%) 437	(5%) <0.001
≥1	Conventional	ECG	abnormality 388	(44%) 1,508	(17%) <0.001
Cedars‐Sinai validation population without conventional abnormal ECG findingsa 
(n = 7,601)
LVEF ≤35% (n = 461) LVEF >35% (n = 7,140) p‐Value
Demographics
Male 336	(73%) 3,660	(51%) <0.001
Age 63.8 ± 16.3 66.3	±	17.4 0.003
Expanded	panel	of	electrocardiographic	variables	in	subset	without	conventional	ECG	abnormalities
Heart rate >85 bpm 215	(47%) 2,193	(31%) <0.001
QRS >110 ms 170	(37%) 1,017	(14%) <0.001
Prolonged	QTc	≥460	ms	men	and	≥470	ms	
women
311	(67%) 1,981	(28%) <0.001
QRS‐T angle >90° 259	(56%) 1,300	(18%) <0.001
Delayed QRS transition 303	(66%) 2,149	(30%) <0.001
Delayed	intrinsicoid	deflection 156	(34%) 412	(5.8%) <0.001
Left	ventricular	hypertrophy 68	(15%) 459	(6.4%) <0.001
PR >200 ms 89	(19%) 834	(12%) <0.001
P‐wave >110 ms 126	(27%) 1,303	(18%) <0.001
Notes. Data are presented as n	(%)	or	mean	±	SD.	All	ECG	parameters	differed	significantly	between	subjects	with	LVEF	≤35%	and	those	with	LVEF	
>35%.
aValidation population: n	=	9,742	inpatients	and	outpatients	from	the	Cedars‐Sinai	hospital	system	with	LVEF	assessed	by	echocardiogram	from	January	
1	to	December	31,	2015	and	ECG	available	within	14	days	of	the	echocardiogram.	Conventional	ECG	abnormalities	evaluated	in	n	=	9,674	patients	
without	acute	myocardial	infarction;	expanded	panel	of	ECG	abnormalities	evaluated	in	n	=	7,601	patients	without	conventional	abnormalities	(ECGs	
in sinus rhythm and without LBBB). 
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3.2.1 | Conventional ECG abnormalities associated 
with reduced LV function
Major	ECG	abnormalities	(AF,	paced	rhythms,	or	LBBB)	were	more	
common	in	patients	with	lower	ejection	fractions	(Figure	1).	At	least	
one	major	ECG	abnormality	was	observed	in	388	(44%)	of	875	sub‐
jects	with	LVEF	≤35%	and	1,508	(17%)	of	8,799	subjects	with	LVEF	
>35%	 (p	<	0.001).	 The	 presence	 of	 AF	was	moderately	 associated	
with	LVEF	≤35%	(OR	1.6,	95%	CI	1.3–1.9),	while	paced	rhythms	(OR	
5.2,	95%	CI	4.3–6.2)	and	LBBB	(OR	4.2,	95%	CI	3.3–5.3)	had	stronger	
associations.	 The	 presence	 of	 any	 one	 of	 these	 abnormalities	 for	
predicting	LVEF	≤35%	produced	a	sensitivity	of	0.443,	specificity	of	
0.829,	PPV	of	0.205,	and	NPV	of	0.937.
3.2.2 | Expanded panel of abnormal ECG markers 
associated with reduced ejection fraction
As	 in	 the	 discovery	 population,	 all	 nine	 of	 the	 expanded	ECG	pa‐
rameters	were	associated	with	LVEF	≤35%	in	univariate	comparisons	
in the validation cohort (p	<	0.001)	 (Table	1).	 In	 the	 multivariable	
model, heart rate, QTc interval, QRS duration, QRS‐T angle, delayed 
QRS	 transition	 zone,	 and	 delayed	 intrinsicoid	 deflection	 remained	
independently	associated	with	LVEF	≤35%,	while	LVH,	prolonged	PR	
interval,	and	prolonged	P	wave	were	not	significant	(Table	2).
Based	 on	 the	 six	 statistically	 significant	 ECG	 markers,	 an	 un‐
weighted	expanded	ECG	panel	sum	was	constructed	ranging	 from	
0	 to	 ≥4	 abnormal	 markers.	 A	 one‐unit	 increase	 in	 the	 panel	 sum	
was	associated	with	2.9‐fold	increased	odds	of	LVEF	≤35%	(OR	2.9;	
95%	CI	2.6–3.1;	C‐statistic 0.831). The ORs remained consistent in 
models	stratified	by	sex	and	age,	ranging	from	2.6	to	3.5.	There	was	
no	significant	interaction	by	sex	with	the	ECG	panel	sum	(p = 0.36). 
The weighted panel sum, constructed as described in the Methods, 
ranged	from	0	to	18,	and	had	a	dose–response	increase	in	odds	of	
LVEF	≤35%,	with	similar	discrimination	(C‐statistic	0.845).	Because	
the	results	were	similar,	we	used	the	unweighted	panel	sum	for	fur‐
ther analysis.
The	expanded	ECG	panel	was	significantly	associated	(p	<	0.001)	
with decreasing LVEF in the validation population. Starting with the 
overall	population,	use	of	the	expanded	panel	in	addition	to	the	con‐
ventional	markers	increased	identification	of	abnormal	ECG	findings	
from	44%	to	65%	among	patients	with	LVEF	≤35%	(Figure	1).
Among	the	subset	of	patients	without	conventional	ECG	ab‐
normalities (n	=	7,601),	 461	 patients	 had	 LVEF	 ≤35%,	 and	 184	
(40%)	of	these	had	an	expanded	ECG	panel	sum	of	at	least	4.	The	
majority	of	patients	without	conventional	ECG	abnormalities	had	
LVEF	>35%	(7,140	of	7,601,	94%),	and	among	these,	only	5%	had	
a	panel	sum	of	≥4.	Conversely,	61%	of	the	7,601	patients	had	≤1	
abnormal	markers,	and	among	them,	only	1.3%	had	LVEF	≤35%.	
Among	 the	 564	 patients	 (7%	 of	 the	 total	 7,601	 patients)	 with	
an	 expanded	 ECG	 panel	 sum	 of	 ≥4,	 184	 (33%)	 had	 LVEF	 ≤35%	
(Figure	2).	For	identification	of	LVEF	≤35%,	a	panel	sum	of	≥4	had	
a	sensitivity	of	0.443,	specificity	of	0.947,	PPV	of	0.326,	and	NPV	
of	0.961.
4  | DISCUSSION
To	our	knowledge,	this	is	the	first	report	of	an	expanded	ECG	marker	
panel that was consistently associated with severely reduced LVEF in 
two	separate	populations.	We	first	identified	a	combination	of	ECG	
ECG parameter
Initial model with all ECG 
parameters
Final model retaining 
parameters if p < 0.10a
Odds ratio (95% 
CI) p‐Value
Odds ratio (95% 
CI) p‐Value
Heart rate >85 bpm 1.9(1.5–2.3) <0.001 1.8 (1.5–2.2) <0.001
QRS >110 ms 1.3 (1.0–1.6) 0.06 1.3 (1.0–1.6) 0.04
QTc	≥460	ms	men;	
≥470	ms	women
2.9 (2.3–3.6) <0.001 2.9 (2.3–3.6) <0.001
QRS‐T angle >90° 2.6 (2.1–3.3) <0.001 2.6 (2.1–3.3) <0.001
Delayed QRS transition 3.1 (2.5–3.9) <0.001 3.1 (2.5–3.9) <0.001
Delayed intrinsicoid 
deflection
5.4	(4.2–6.9) <0.001 5.5	(4.3–7.1) <0.001
Left	ventricular	
hypertrophy
1.0	(0.7–1.4) 0.90 –
PR >200 ms 1.1	(0.8–1.4) 0.64 –
P‐wave >110 ms 1.2 (0.9–1.6) 0.13 –
Note. aInitial multivariable model included all ECG parameters. Final multivariable model resulted 
from	stepwise	logistic	regression,	with	p	<	0.30	to	enter	model	and	p	<	0.10	to	retain	in	model.	Left	
ventricular	hypertrophy,	prolonged	PR	interval	and	P‐wave	duration	did	not	remain	significant,	were	
omitted	from	the	final	model,	and	were	not	included	in	the	abnormal	ECG	marker	total.	C‐statistic	of	
the	model	was	0.846,	goodness‐of‐fit	test	p = 0.11. 
TA B L E  2   Electrocardiogram (ECG) 
parameters	associated	with	left	
ventricular	ejection	fraction	≤35%	in	the	
multivariable model and included in the 
expanded abnormal ECG marker total, in 
the Cedars‐Sinai validation population
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markers	associated	with	severely	reduced	LV	function	in	a	discovery	
population	and	then	validated	our	findings	in	a	separate	health‐sys‐
tem	population.	Among	patients	with	major	ECG	abnormalities	that	
are conventionally associated with LVEF, such as atrial arrhythmias, 
LBBB,	 and	paced	 rhythms,	20%	had	LVEF	≤35%.	 In	 the	 remaining	
patients	without	conventional	ECG	abnormalities,	 six	specific	ECG	
parameters (resting heart rate >85 bpm, QRS duration >110 ms, pro‐
longed QTc interval, QRS‐T angle >90°, delayed QRS transition, and 
delayed	intrinsicoid	deflection)	remained	independently	associated	
with	LVEF	≤35%.	A	finding	of	≥4	abnormal	ECG	markers	correlated	
strongly	with	LVEF	≤35%.	On	the	other	hand,	in	individuals	with	one	
or no abnormal ECG markers, severely reduced LVEF was an exceed‐
ingly	rare	finding.
Published studies have reported a correlation between abnor‐
mal	ECG	diagnoses	such	as	atrial	fibrillation,	LBBB,	ventricular	paced	
rhythms	and	 reduced	LVEF;	and	 in	clinical	practice,	 these	 findings	
generally prompt clinicians to evaluate the LVEF (Baker, Bahler, 
Finkelhor,	&	Lauer,	2003;	Davie	et	al.,	1996;	Nielsen,	Hansen,	Hilden,	
Larsen,	&	Svanegaard,	2000;	Olesen	&	Andersen,	2016;	Rihal,	Davis,	
Kennedy,	 &	 Gersh,	 1995;	 Talreja,	 Gruver,	 Sklenar,	 Dent,	 &	 Kaul,	
2000).	Our	results	are	also	consistent	with	these	established	find‐
ings.	However,	a	large	subgroup	of	patients	will	have	reduced	LVEF	
in	the	absence	of	these	conventionally	accepted	ECG	markers	(Baker	
et	al.,	2003;	Olesen	&	Andersen,	2016).	As	a	consequence,	there	is	
substantial	room	for	improvement	for	identification	of	patients	with	
severely reduced LVEF.
Therefore,	 we	 examined	 an	 expanded	 panel	 of	 abnormal	 ECG	
markers	that	are	not	currently	considered	as	 indicators	of	LVSD	in	
clinical practice. The association between several individual ECG 
markers and LVSD has been previously reported. For example, in‐
creased resting heart rate has been associated with reduced LVEF 
even in asymptomatic individuals in the general population (Opdahl 
et	al.,	2014).	Several	studies	among	HF	patients	and	other	popula‐
tions	have	linked	QRS	prolongation	with	decreased	LV	systolic	func‐
tion	(Ilkhanoff	et	al.,	2012;	Lund	et	al.,	2013;	Murkofsky	et	al.,	1998).	
However,	early	attempts	to	directly	estimate	LV	function	using	mea‐
sures	of	QRS	morphology	from	the	ECG	had	limited	success	(Young,	
Abouantoun,	Savvides,	Madsen,	&	Froelicher,	1983).	The	more‐spe‐
cific	depolarization	measures	included	in	the	expanded	panel,	that	is,	
delayed	 intrinsicoid	deflection	 (Darouian	et	al.,	2016;	O’Neal	et	al.,	
2016)	and	QRS	transition	zone	 (Aro	et	al.,	2017),	were	 individually	
associated with low LVEF. In addition, prolonged QTc‐interval and 
wide	QRS‐T	angle	have	been	associated	with	LV	dysfunction	(Davey,	
2000; Pavri et al., 2008). However, to our knowledge, these ECG 
markers have not been previously combined to examine their joint 
association with LVSD.
In	our	validation	study	population,	after	excluding	patients	with	
major	 ECG	 abnormalities	 conventionally	 associated	with	HF,	 7.4%	
of	patients	had	≥4	abnormal	ECG	 findings,	 and	one‐third	of	 these	
patients	had	evidence	of	severe	LVSD.	In	this	heterogeneous	popu‐
lation,	positive	and	negative	predictive	values	of	having	≥4	abnormal	
ECG	markers	were	higher	 than	 those	of	 the	 traditional	major	ECG	
abnormalities	(Lieberman,	2010).	Furthermore,	60%	of	the	patients	
had	only	0–1	ECG	abnormalities,	and	in	this	group,	the	prevalence	of	
LVEF	≤35%	was	under	1.5%.	This	observation,	 in	accordance	with	
previous reports (Nielsen et al., 2000), suggests that a normal ECG 
virtually	excludes	severe	LVSD.	Together,	these	findings	imply	that	
a	markedly	abnormal	electrical	profile,	even	in	the	absence	of	other	
conventionally used major ECG abnormalities, is strongly correlated 
with	LV	systolic	function.
There	are	several	factors	that	could	explain	the	relationship	be‐
tween	increasing	number	of	ECG	abnormalities	and	decreased	LVEF.	
F I G U R E  2   Using the expanded 
electrocardiogram	(ECG)	panel,	33%	of	
patients	with	an	expanded	panel	sum	of	
≥4	(4	or	more	abnormal	ECG	markers)	had	
severe	left	ventricular	systolic	dysfunction
Heart rate >85 bpm
QRS 
transition 
>V4
QRS 
duration 
>110 ms
Frontal 
QRS-T angle 
>90°
QTc interval 
≥460/470 ms
Expanded ECG panel
Sum ≥4
1 in 3 had severe
LV systolic dysfunction by echocardiography
Resting 12-lead electrocardiogram
Delayed QRS
intrinsicoid 
deection ≥50 ms 
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Pathologic LV remodeling in ischemic or nonischemic cardiomyop‐
athy	has	electrical	components	 that	are	 reflected	as	abnormalities	
in cardiac conduction and myocardial depolarization/repolarization 
markers	(Davey,	2000;	Ilkhanoff	et	al.,	2012).	As	highlighted	recently	
(Aro	&	Chugh,	2016),	 structural	and	electrical	 remodeling	contrib‐
ute	 independently	 to	 risk	 of	morbidity	 and	mortality.	Another	 es‐
tablished	manifestation	of	the	HF	syndrome	is	abnormal	autonomic	
remodeling,	reflected	by	increased	resting	heart	rate	(Floras,	2009;	
Opdahl	et	al.,	2014).
4.1 | Study limitations
The	 strengths	 of	 this	 study	 lie	 in	 discovery	 and	 validation	 of	 an	
expanded	panel	 of	 abnormal	ECG	markers	 and	LVEF	 in	 two	 sepa‐
rate	populations,	and	in	the	large	size	of	the	validation	population.	
However, some potential limitations should be considered while in‐
terpreting	these	findings.	As	the	analysis	was	restricted	to	subjects	
undergoing echocardiographic examination, these could represent a 
subgroup	of	patients	with	higher	morbidity.	In	addition,	the	overall	
prevalence	of	LVSD	was	 relatively	high:	16%	 in	 the	Oregon	SUDS	
population	(a	population	enriched	for	SCA	cases	and	coronary	dis‐
ease),	 and	 9%	 in	 our	 validation	 study	 population	 of	 largely	 hospi‐
talized	patients.	Although	the	consistency	of	associations	between	
ECG	parameters	and	LVEF	in	these	two	very	different	populations	
is encouraging, nonetheless these results may not be generalizable 
to the general population or to a purely out‐patient population. 
However,	among	a	combination	of	outpatient	and	hospitalized	pa‐
tients,	a	set	of	relatively	easily	obtained	ECG	markers	was	strongly	
correlated	with	 severe	 LVSD	 (Galasko,	Barnes,	Collinson,	 Lahiri,	&	
Senior, 2006).
5  | CONCLUSIONS
A	panel	of	multiple,	broadly	available	ECG	markers	was	 strongly	
associated	with	findings	of	severely	reduced	LV	systolic	function.	
These	findings	may	have	potential	for	improving	detection	of	se‐
vere	 LVSD,	with	 the	possibility	 of	 improving	 early	 diagnosis	 and	
management	of	patients	if	prospective	community‐based	studies	
corroborate	the	effectiveness	of	this	expanded	panel	of	abnormal	
ECG markers.
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